跳至主要内容
临床试验/IRCT20150630022991N10
IRCT20150630022991N10招募中2 期

Comparison of the Efficacy of Escitalopram, Venlafaxine and Buspirone on the Symptoms and Quality of Life in Irritable Bowel Syndrome Patients

Babol University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • The Presence of ROME-III Diagnostic Criteria for Diagnosis of Irritable Bowel Syndrome
  • To Provide the Informed Consent Form of the Patient for Participation in the Study

排除标准

  • Age under 18 years
  • Allergy to Escitalopram, Venlafaxine or Buspirone
  • The presence of warning signs such as chronic fever, weight loss, gastrointestinal bleeding
  • Pregnancy and breast feeding
  • Use of any drug that can affect the bowel function (such as laxatives, anti-diarrhea, antibiotics and probiotics) within one month before entering the study
  • Known cases of lactose intolerance
  • Severe physical illnesses, mental retardation, dementia, psychosis, and the existence of serious suicidal ideation and substance dependence that affects patients' compliance with the study protocol

研究者

相似试验